Partnering Webinar: Detection of SARS-CoV-2 and other RNA Viruses Using a Novel Improved RT-qPCR Method that Increases Detection Sensitivity and Improves Safety

NIH researchers will highlight a novel Covid-19 diagnostic technology from the National Eye Institute (NEI). NEI is seeking partners for collaboration and licensing to accelerate technology development and clinical benefit. The novel sample preparation method uses a chelating resin, which eliminates the RNA extraction step and shortens the overall testing time. This fast RNA preparation and detection method can be used for a variety of sample types, is safe for clinical staff, and is suitable for standard clinical collection and high-volume testing for both DNA and RNA.